These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 27344366)

  • 1. RNAi delivery by exosome-mimetic nanovesicles - Implications for targeting c-Myc in cancer.
    Lunavat TR; Jang SC; Nilsson L; Park HT; Repiska G; Lässer C; Nilsson JA; Gho YS; Lötvall J
    Biomaterials; 2016 Sep; 102():231-8. PubMed ID: 27344366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exosomes are natural carriers of exogenous siRNA to human cells in vitro.
    Shtam TA; Kovalev RA; Varfolomeeva EY; Makarov EM; Kil YV; Filatov MV
    Cell Commun Signal; 2013 Nov; 11():88. PubMed ID: 24245560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineering extracellular vesicles mimetics for targeted chemotherapy of drug-resistant ovary cancer.
    Liu X; Liu G; Mao Y; Luo J; Cao Y; Tan W; Li W; Yu H; Jia X; Li H
    Nanomedicine (Lond); 2024 Jan; 19(1):25-41. PubMed ID: 38059464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arrowtail RNA for Ligand Display on Ginger Exosome-like Nanovesicles to Systemic Deliver siRNA for Cancer Suppression.
    Li Z; Wang H; Yin H; Bennett C; Zhang HG; Guo P
    Sci Rep; 2018 Oct; 8(1):14644. PubMed ID: 30279553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proof-of-Concept Study on the Use of Tangerine-Derived Nanovesicles as siRNA Delivery Vehicles toward Colorectal Cancer Cell Line SW480.
    Rabienezhad Ganji N; Urzì O; Tinnirello V; Costanzo E; Polito G; Palumbo Piccionello A; Manno M; Raccosta S; Gallo A; Lo Pinto M; Calligaris M; Scilabra SD; Di Bella MA; Conigliaro A; Fontana S; Raimondo S; Alessandro R
    Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exosome mediated delivery of functional nucleic acid nanoparticles (NANPs).
    Nordmeier S; Ke W; Afonin KA; Portnoy V
    Nanomedicine; 2020 Nov; 30():102285. PubMed ID: 32781137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electroporation Knows No Boundaries: The Use of Electrostimulation for siRNA Delivery in Cells and Tissues.
    Luft C; Ketteler R
    J Biomol Screen; 2015 Sep; 20(8):932-42. PubMed ID: 25851034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global Identification of Human Exosome Substrates Using RNA Interference and RNA Sequencing.
    Lloret-Llinares M; Jensen TH
    Methods Mol Biol; 2020; 2062():127-145. PubMed ID: 31768975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engineered targeting tLyp-1 exosomes as gene therapy vectors for efficient delivery of siRNA into lung cancer cells.
    Bai J; Duan J; Liu R; Du Y; Luo Q; Cui Y; Su Z; Xu J; Xie Y; Lu W
    Asian J Pharm Sci; 2020 Jul; 15(4):461-471. PubMed ID: 32952669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient-Derived Exosomes as siRNA Carriers in Ovarian Cancer Treatment.
    Shimizu A; Sawada K; Kobayashi M; Oi Y; Oride T; Kinose Y; Kodama M; Hashimoto K; Kimura T
    Cancers (Basel); 2024 Apr; 16(8):. PubMed ID: 38672564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plant-derived exosome-like nanovesicles: A novel nanotool for disease therapy.
    Jin Z; Na J; Lin X; Jiao R; Liu X; Huang Y
    Heliyon; 2024 May; 10(9):e30630. PubMed ID: 38765146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-
    Habib S; Ariatti M; Singh M
    Biomedicines; 2020 Dec; 8(12):. PubMed ID: 33333729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hitching a ride on exosomes: a new approach for the delivery of siRNA-mediated therapies.
    Snyder A; Grunseich C
    Brain; 2021 Dec; 144(11):3286-3287. PubMed ID: 34918045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional exosome-mimic for delivery of siRNA to cancer: in vitro and in vivo evaluation.
    Yang Z; Xie J; Zhu J; Kang C; Chiang C; Wang X; Wang X; Kuang T; Chen F; Chen Z; Zhang A; Yu B; Lee RJ; Teng L; Lee LJ
    J Control Release; 2016 Dec; 243():160-171. PubMed ID: 27742443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional Delivery of Lipid-Conjugated siRNA by Extracellular Vesicles.
    O'Loughlin AJ; Mäger I; de Jong OG; Varela MA; Schiffelers RM; El Andaloussi S; Wood MJA; Vader P
    Mol Ther; 2017 Jul; 25(7):1580-1587. PubMed ID: 28392161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post isolation modification of exosomes for nanomedicine applications.
    Hood JL
    Nanomedicine (Lond); 2016 Jul; 11(13):1745-56. PubMed ID: 27348448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular vesicle mimetics: Novel alternatives to extracellular vesicle-based theranostics, drug delivery, and vaccines.
    Kim OY; Lee J; Gho YS
    Semin Cell Dev Biol; 2017 Jul; 67():74-82. PubMed ID: 27916566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exosome-mediated Delivery of Hydrophobically Modified siRNA for Huntingtin mRNA Silencing.
    Didiot MC; Hall LM; Coles AH; Haraszti RA; Godinho BM; Chase K; Sapp E; Ly S; Alterman JF; Hassler MR; Echeverria D; Raj L; Morrissey DV; DiFiglia M; Aronin N; Khvorova A
    Mol Ther; 2016 Oct; 24(10):1836-1847. PubMed ID: 27506293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Donor dendritic cell-derived exosomes promote allograft-targeting immune response.
    Liu Q; Rojas-Canales DM; Divito SJ; Shufesky WJ; Stolz DB; Erdos G; Sullivan ML; Gibson GA; Watkins SC; Larregina AT; Morelli AE
    J Clin Invest; 2016 Aug; 126(8):2805-20. PubMed ID: 27348586
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.